Y. Yuki

Cationic nanogel-based nasal therapeutic HPV vaccine prevents the development of cervical cancer.
20251 citationsauthor #3
MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system
20248 citationsauthor #1
Replication of Human Sapovirus in Human-Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells
20234 citationsauthor #8
Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents
202311 citationsauthor #3
Genotype Diversity of Enteric Viruses in Wastewater Amid the COVID-19 Pandemic
202314 citationsauthor #7
Biodistribution assessment of cationic pullulan nanogel, a nasal vaccine delivery system, in mice and non-human primates.
20235 citationsauthor #1
A review of criteria strictness in "Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials".
202356 citationsauthor #3
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection
202212 citationsauthor #1
Induction of Mucosal IgA–Mediated Protective Immunity Against Nontypeable Haemophilus influenzae Infection by a Cationic Nanogel–Based P6 Nasal Vaccine
202213 citationsauthor #3
Abundance of Viral Gastroenteritis before and after the Emergence of COVID-19: Molecular Evidence on Wastewater
20220 citationsauthor #7
Abundance of viral gastroenteritis before and after the emergence of COVID-19: Molecular evidence on wastewater
20227 citationsauthor #7
Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults.
202218 citationsauthor #1
Nasal vaccines: solutions for respiratory infectious diseases.
202238 citationsauthor #4
Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial.
202141 citationsauthor #1
Pancreatic glycoprotein 2 is a first line of defense for mucosal protection in intestinal inflammation
202155 citationsauthor #17
Development of Antibody-Fragment–Producing Rice for Neutralization of Human Norovirus
202115 citationsauthor #2
A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci.
202141 citationsauthor #3
Characterization and Specification of a Trivalent Protein-Based Pneumococcal Vaccine Formulation Using an Adjuvant-Free Nanogel Nasal Delivery System.
202125 citationsauthor #1
Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine
20213 citationsauthor #2
Mucosal vaccines: wisdom from now and then
202125 citationsauthor #2
Nanodelivery Vehicles for Mucosal Vaccines
20200 citationsauthor #2
Development of Nanogel-based Nasal Vaccine against Pneumonia
20201 citationsauthor #2
A heterodimeric antibody fragment for passive immunotherapy against norovirus infection.
20209 citationsauthor #1
Metagenome Data on Intestinal Phage-Bacteria Associations Aids the Development of Phage Therapy against Pathobionts.
202067 citationsauthor #13
Plant-Based Mucosal Vaccine Delivery Systems
20192 citationsauthor #2
Antigen-specific Mucosal Immunity Regulates Development of Intestinal Bacteria-mediated Diseases.
201931 citationsauthor #13
Needle- and Cold Chain- Free Rice-Based Oral Vaccine, MucoRice-CTB Shows Microbiota-Dependent Immunogenicity in Humans
20191 citationsauthor #1
A role for the CCR5–CCL5 interaction in the preferential migration of HSV-2-specific effector cells to the vaginal mucosa upon nasal immunization
20199 citationsauthor #9
Title Some Properties of a Yeast Cell Lytic Enzyme from Pellicularia sasaki, Especially Referring to Thermal Denaturation (Commemoration Issue Dedicated to Professor
20180 citationsauthor #1
PNEUMOCOCCAL VACCINE COMBINING SELECTED ALPHA HELICAL DOMAINS AND PROLINE RICH DOMAINS OF PNEUMOCOCCAL SURFACE PROTEIN A
20180 citationsauthor #6
Human Norovirus Propagation in Human Induced Pluripotent Stem Cell–Derived Intestinal Epithelial Cells
201865 citationsauthor #7
Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases
201842 citationsauthor #2
Intranasal vaccination against angiotensin II type 1 receptor and pneumococcal surface protein A attenuates hypertension and pneumococcal infection in rodents
201826 citationsauthor #2
Mar , 1986 EFFECTIVE SEPARATION OF HUMAN CHORIONIC GONADOTROPIN SUBUNITS BY HIGH PERFORMANCE GEL PERMEATION CHROMATOGRAPHY
20170 citationsauthor #1
Development of a nanogel-based nasal vaccine as a novel antigen delivery system
201733 citationsauthor #2
A Refined Culture System for Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Organoids
2017104 citationsauthor #6
Nanogel-based nasal ghrelin vaccine prevents obesity
201742 citationsauthor #2
Title Purification and Properties of a Yeast Cell Lytic Enzyme from Pellicularia sasaki (Commemoration Issue Dedicated to Professor Tatsuo Yamamoto on the Occasion of his Retirement)
20170 citationsauthor #5
Nanogel-based nasal vaccines for infectious and lifestyle-related diseases.
201716 citationsauthor #2
Differential analyses of major allergen proteins in wild-type rice and rice producing a fragment of anti-rotavirus antibody.
20164 citationsauthor #1
The effect of mucoadhesive excipient on the nasal retention time of and the antibody responses induced by an intranasal influenza vaccine.
201633 citationsauthor #6
ISH NIA OS-02 ATTENUATION OF HYPERTENSION BY LESS-INVASIVE INTRANASAL VACCINATION AGAINST ANGIOTENSIN II TYPE 1 RECEPTOR IN SPONTANEOUSLY HYPERTENSIVE RATS
20160 citationsauthor #2
Critical role of TSLP-responsive mucosal dendritic cells in the induction of nasal antigen-specific IgA response
201626 citationsauthor #4
ISH NIA OS-02 ATTENUATION OF HYPERTENSION BY LESS-INVASIVE INTRANASAL VACCINATION AGAINST ANGIOTENSIN II TYPE 1 RECEPTOR IN SPONTANEOUSLY HYPERTENSIVE RATS.
20160 citationsauthor #2
Oral rice-based vaccine induces passive and active immunity against enterotoxigenic E. coli-mediated diarrhea in pigs.
201530 citationsauthor #2
Structural basis of blocking integrin activation and deactivation for anti-inflammation
201541 citationsauthor #2
Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques
201596 citationsauthor #2
Plant-based vaccines for animals and humans: recent advances in technology and clinical trials
2015146 citationsauthor #3
Comparative whole-genome analyses of selection marker–free rice-based cholera toxin B-subunit vaccine lines and wild-type lines
20150 citationsauthor #6
Comparative whole-genome analyses of selection marker–free rice-based cholera toxin B-subunit vaccine lines and wild-type lines
201514 citationsauthor #6
Structural basis of blocking integrin activation and deactivation for anti-inflammation
20150 citationsauthor #2
Nasal Administration of Cholera Toxin as a Mucosal Adjuvant Damages the Olfactory System in Mice
201530 citationsauthor #6
Profiles of microRNA networks in intestinal epithelial cells in a mouse model of colitis
201546 citationsauthor #3
Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants
201531 citationsauthor #2
Nanogel-based PspA nasal vaccine induces microRNA-associated protective immunity in nonhuman primates (MUC4P.834)
20140 citationsauthor #2
Determination of genomic location and structure of the transgenes in marker-free rice-based cholera vaccine by using whole genome resequencing approach
201410 citationsauthor #10
A rice-based soluble form of a murine TNF-specific llama variable domain of heavy-chain antibody suppresses collagen-induced arthritis in mice.
201417 citationsauthor #2
Challenges in mucosal vaccines for the control of infectious diseases.
2014109 citationsauthor #2
Self-Assembled Polysaccharide Nanogels for Nasal Delivery of Biopharmaceuticals
20145 citationsauthor #2
Determination of genomic location and structure of the transgenes in marker-free rice-based cholera vaccine by using whole genome resequencing approach
20140 citationsauthor #10
Specific Expression of Apolipoprotein A-IV in the Follicle-Associated Epithelium of the Small Intestine
20148 citationsauthor #8
Novel Transgenic Rice-Based Vaccines
201427 citationsauthor #4
RNAi-mediated suppression of endogenous storage proteins leads to a change in localization of overexpressed cholera toxin B-subunit and the allergen protein RAG2 in rice seeds
201326 citationsauthor #12
Colonization by Streptococcus pneumoniae Prevents Invasive Disease and Nasal Nanogel-Based PspA Intranasal Vaccine
20130 citationsauthor #12
MucoRice-cholera toxin B-subunit, a rice-based oral cholera vaccine, down-regulates the expression of α-amylase/trypsin inhibitor-like protein family as major rice allergens.
201326 citationsauthor #12
Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification.
201361 citationsauthor #1
Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection.
201386 citationsauthor #18
Nanogel-Based PspA Intranasal Vaccine Prevents Invasive Disease and Nasal Colonization by Streptococcus pneumoniae
2013130 citationsauthor #3
Potential Roles of CCR5+ CCR6+ Dendritic Cells Induced by Nasal Ovalbumin plus Flt3 Ligand Expressing Adenovirus for Mucosal IgA Responses
201312 citationsauthor #12
RNAi-mediated suppression of endogenous storage proteins leads to a change in localization of overexpressed cholera toxin B-subunit and the allergen protein RAG2 in rice seeds
20131 citationsauthor #12
Nanogel-based antigen-delivery system for nasal vaccines
201333 citationsauthor #1
RNAi suppression of rice endogenous storage proteins enhances the production of rice-based Botulinum neutrotoxin type A vaccine.
201230 citationsauthor #1
Adjuvant-free nanogel-based PspA nasal vaccine for the induction of protective immunity against Pneumococcus (166.7)
20126 citationsauthor #1
Transcription factor Spi-B–dependent and –independent pathways for the development of Peyer’s patch M cells
2012101 citationsauthor #6
Novel vaccine development strategies for inducing mucosal immunity
2012141 citationsauthor #6
Passive oral rice-based antibody prophylaxis and therapy against rotavirus infection (106.19)
20111 citationsauthor #17
In vivo molecular imaging for a nasal botulism vaccine in mice and nonhuman primates
20110 citationsauthor #1
[Current progress in the development of mucosal vaccines].
20110 citationsauthor #2
In vivo molecular imaging for a nasal botulism vaccine in mice and nonhuman primates (53.8)
20110 citationsauthor #1
New Strategy for the Control of Infectious and Immunological Diseases by the Fusion of Medical and Agriculture Science: Development of Rice-based Oral Vaccine
20110 citationsauthor #2
Distinct fucosylation of M cells and epithelial cells by Fut1 and Fut2, respectively, in response to intestinal environmental stress.
201154 citationsauthor #12
The mucosal immune system for secretory IgA responses and mucosal vaccine development
20105 citationsauthor #4
Nanogel antigen delivery system for adjuvant-free intranasal vaccines (46.16)
20100 citationsauthor #2
Antigen-sampling cells in the salmonid intestinal epithelium.
2010122 citationsauthor #6
In Vivo Molecular Imaging Analysis of a Nasal Vaccine That Induces Protective Immunity against Botulism in Nonhuman Primates
201032 citationsauthor #1
Immunity against Botulism in Nonhuman Nasal Vaccine That Induces Protective In Vivo Molecular Imaging Analysis of a and
20100 citationsauthor #1
A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing Abs but does not influence natural intestinal immunity
20101 citationsauthor #1
Secretory IgA responses induced by rice-based oral cholera toxin B subunit vaccine are solely responsible for antibody-mediated long-standing cross-protection against Vibrio cholerae - and enterotoxigenic Escherichia coli -induced diarrhea (46.3)
20100 citationsauthor #2
Mucosal vaccines (WS-049) Chairpersons: Jun Kunisawa, Mi-Na Kweon
20100 citationsauthor #26
Mucosal vaccines (PP-049)
20100 citationsauthor #27
The effect of liposome-coated recombinant protein VP28 against white spot syndrome virus in kuruma shrimp, Marsupenaeus japonicus.
201033 citationsauthor #11
Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine
2010106 citationsauthor #2
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines.
2010425 citationsauthor #2
Transgenic Rice for Mucosal Vaccine and Immunotherapy
20100 citationsauthor #1
A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing Abs but does not influence natural intestinal immunity (46.4)
20100 citationsauthor #1
Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis
2010215 citationsauthor #13
Mucosal vaccines: novel advances in technology and delivery
2009104 citationsauthor #1
New horizon of mucosal immunity and vaccines.
200960 citationsauthor #3
mucosal vaccine employing cationic nanogel
20090 citationsauthor #3
Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity.
200944 citationsauthor #1

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT